Introduction
============

All health systems around the world have faced rising health care expenditures, which threaten their ability to deliver good quality care in an equitable manner. Health care expenditures in Iran have been accelerating rapidly in past years ([Table 1](#t1-ijph-41-14){ref-type="table"}) and have placed serious resource pressures on the health system. This in turn has created additional pressures for health insurance organisations, policy makers and the Iranian population. Considering the fact that more than 90 percent of health care services are providing by the state- such pressures have encouraged health policy makers to consider the potential role that the privately funded sector can play in providing an alternative to public sector services.

As health care expenditures increased, the questions of efficiency and equity were confronted simultaneously. Health care financing in Iran is based on social insurance and is a pluralistic funding system ([@b1-ijph-41-14]). There are three main sources of health care funding in Iran; general government budget, health insurance payments and individuals' out of pocket expenses. The size of the health budget is determined by the deputy of the president in Management & Planning in close collaboration with the financial department of the Ministry of Health & Medical Education (MH&ME). This budget must then be approved by the cabinet and subsequently by parliament.

Iran has four main health insurance organisations; the Social Security Insurance Organisation (SSIO), the Medical Services Insurance Organisation (MSIO), the Armed Forces Medical Services Insurance Organisation (AFMSIO), and the Imdad Committee Health Insurance (ICHI). All of these organisations benefit from government support at various levels ([@b1-ijph-41-14]). Iran spent 220 Million US\$ for its health in year 2008 ([Table 1](#t1-ijph-41-14){ref-type="table"}) ([@b2-ijph-41-14], [@b3-ijph-41-14]).

Despite this level of expenditure there remained considerable financial difficulties for the government, as the main providers of health care, for health insurance organisations, as the main purchasers of health care services, and for the patients, as the consumers of health care. We have attempted to elucidate such issues by a series of interviews with key opinion leaders within the Iranian healthcare system and point out possible interrelated links between them, as part of a wider study, which undertook a comprehensive evaluation of each component of the Iranian health system.

Methods
=======

This study is a part of larger study evaluating the application of health technology assessment (HTA) programme in Iran ([@b4-ijph-41-14]). It provides an overview of health care system performance in the whole. This study uses mixed methods. A systematic literature search was undertaken of electronic databases including MEDLINE, EMBASE, and Google Scholar. This was supplemented by searching in local books and journals including, Government publications, Iranian Journal of Public Health, and Iranian news agencies including Islamic Republic News Agency (IRNA), Iranian Students News Agency (ISNA), Iranian Labour News Agency (ILNA), and Fars News Agency. The issues and uncertainties identified were explored further qualitatively, by semi-structured interviews with key informants. These were selected by purposive sampling ([@b5-ijph-41-14]), to cover government, relevant professions and health service administrators.

Due to the limited published materials, much of the evidence concerning financing of the Iranian health care system has been obtained through face-to-face interviews with key personnel supported by an extensive review of government publications and other 'grey' literature.

The interviews were recorded, transcribed, coded, classified, translated and presented using thematic analysis ([@b6-ijph-41-14]). These were triangulated with empirical evidence in the form of the literature, government statistics and independent expert opinions to validate the views expressed in the interviews.

The results of the interviews are presented anonymously to ensure as honest a response as possible, but it is important to be aware of the interviewee's roles and possible perspectives: these are summarised in [Table 2](#t2-ijph-41-14){ref-type="table"}.

Results
=======

The systematic review of published literature was unable to identify any previous publication regarding financing of healthcare services in Iran. However, there are many personal comments and interviews with news agencies, which helped to identify issues to be explored further in the interviews.

The initial selection of interviewees for the whole study consisted of 60 senior healthcare managers. Following the initial invitation, 38 interviews were actually undertaken consisting of 12 interviewees from the healthcare delivery system, 11 and 15 from the pharmaceutical division. However, considering the results of the interviews, it become clear that 21 of the interviewees offered comments related to the financing of the healthcare system. The interviewees' positions are summarized in [Table 2](#t2-ijph-41-14){ref-type="table"}.

The interviewees raised various types of concerns relating to financing of the health system. We summarized them into four main issues: over use of health care services, lack of health economic expertise in health care management, high out of pocket expenditures and issues relating to privatization.

Excessive use of health services
--------------------------------

The interviewees considered that there was over use of health care services in past years. They believed this problem has wasted significant amount of financial resources in the health care delivery system. They suggested three main reasons for this over use: the nature and structure of health care delivery system in Iran, enhanced expectations of the patients, and poor monitoring.

Almost all of the subjects believed that the structure of healthcare delivery system directly led to the over utilization of health care services. They stated that the patients freedom of choice of clinician made it impossible to implement any systematic referral system, which made patients, use of the various levels of the services haphazard. This issue has been discussed in greater detail elsewhere ([@b7-ijph-41-14]).

In addition, of the nature of healthcare delivery system, the interviewees argued that expectations, demands for new, and high technology services, such as new drugs and imaging techniques have significantly increased in recent years. They believed that these expectations far exceeded the ability of the health insurance organisations to meet them. Issues related to health insurance system in Iran are also discussed in detail elsewhere ([@b1-ijph-41-14]).

Lack of effective monitoring, was considered the third important reason for over using medical services within the Iranian healthcare system.

Empirical evidence supports this: Dr Fazel, an ex-minister of health and the head of Iranian society of surgeons, and Dr Ghasemi, the head of Iranian heart association, have stated publicly that considerable numbers of unnecessary angiographies are undertaken in Iran ([@b8-ijph-41-14]). Recent studies also show an exceptional growth in utilization of caesarean delivery ([@b9-ijph-41-14],[@b10-ijph-41-14]).

Lack of health economic expertise
---------------------------------

The interviewees believed many issues originated from the lack of economic expertise in health care management. Such issues generally related to limited financial resources, unrealistic medical tariffs, and profit sharing.

Many senior health authority managers have also publicly support these comments. For example, Dr M. V. Dastjerdi ([@b11-ijph-41-14]), minister of health, Dr I. Fazel ([@b12-ijph-41-14]), the ex-minister of health, and Dr Zafarghandi ([@b13-ijph-41-14]), the ex-chancellor of Tehran Medical University, stated that no economic approach was undertaken in managing the health system. Dr Fazel judged that this approach not only has reduced the quality of care, but also has undermined medical ethics ([@b12-ijph-41-14]).

### Limited financial resources

An important concern of the interviewees was the perceived shortage of financial resources, due to the combination of a significant increase in health care costs and an inadequate per capita expenditure on health care (PCEHC). Such issues are discussed in more detail elsewhere ([@b1-ijph-41-14]).

### Low Medical tariffs (medical fees)

Several interviewees severely criticized the process and the method underlying the determination of the medical tariffs paid for defined diagnoses. They stated that the process is challenging because the main buyers of health services, the health insurance organisations via the Higher Insurance Council (HIC), have the power to determine the medical tariffs. The interviewees perceived that this has led, the HIC to set medical tariffs below the market value of the services provided. A recent study also showed that this process has caused many problems even for health insurance organisations ([@b1-ijph-41-14]).

In addition to the level of medical tariffs, the method of their determination also received significant criticism. It was felt that the HIC focuses strongly on affordability of health insurance organisations, rather than the cost and effectiveness of the services. They argued that this has consequently led to considerable difficulties for both, health care providers as well as the patients.

### Profit Sharing

Profits arising from medical services i.e. laboratory test, radiography, CT or MRI Scan, is often shared between those doctors who recommend the services and those who undertake it. This was considered by our interviewees an inevitable consequence of the unrealistic medical tariffs.

Such supplier-induced demand for medical services in Iran inevitably leads to a significant over utilisation of health care services without any commensurate increase in health benefits to the patient, creating allocative and technical inefficiency in the system ([@b14-ijph-41-14], [@b15-ijph-41-14]).

High out of pocket expenditures
-------------------------------

Out of pocket spending by patients received considerable attention from the interviewees. They suggested two main causes for the comparatively high level of private health expenditure in Iran which is around 60%; Firstly the prevalence and size of under the table fees, and secondly the comparative ineffectiveness of health insurance coverage.

### Under the table fees

Considerable numbers of the interviewees strongly criticised the existence of irregular, under the table fees paid by patients to doctors. While they believed that this has damaged medical dignity and medical ethics significantly, again they perceived that low medical tariffs were the main cause of the problem.

The interviewees argued that doctors and other health professionals working in the private sector had no alternative to making additional charges if they were to be able to buy equipment and medicines at market prices. An alternative response to low medical tariffs is to reduce their quality care in order to reduce their services' costs.

The responses of the interviewees emphasised that the problem of unrealistically low medical tariffs causes problems for all parts of the Iranian healthcare system. It has consequently led to the disequilibrium of the health care market through the development of a black market and by adversely affecting the quality of care provided.

### Ineffective health insurance coverage

The interviewees believed that ineffective health insurance coverage was also one of the principal causes of high out of pocket health expenditures in Iran. They stated that every year health insurance organisations (HIOs) reduce their health care coverage by, for example, refusing to fund new medicines mainly as a direct consequence of their financial difficulties. In such circumstances, it is not surprising that patients choose to pay for such services from their own pocket.

Empirical evidence, including recent studies ([@b1-ijph-41-14],[@b16-ijph-41-14],[@b17-ijph-41-14]) and governmental reports ([@b18-ijph-41-14]) also support this theme.

The money cycle in health care market in Iran shows that the population pay various kinds of the payments within the health care market ([Fig. 1](#f1-ijph-41-14){ref-type="fig"}). This may help to understand why numerous families fall below the poverty line each year as a direct consequence of their health care expenditures ([@b18-ijph-41-14], [@b19-ijph-41-14]).

It can be expected that the greatest problems be imposed on the poorest members of Iranian society whose needs for health services are greatest, due to poor housing and diet.

The potential for enhanced privatization of health care
-------------------------------------------------------

Some interviewees believed that improving private health care services could help the system to improve its services in both quality and quantity. It has been stated that because of limited resources, the government is not able to provide health care services for all; and therefore it is necessary to find a new way to meet the financial needs of the system. Some senior policy makers, such as Dr Larijani ([@b20-ijph-41-14]), the parliament speaker, have also stated that the private sector should take more responsibilities in providing health care services.

A range of recent policy developments show that this theme is developing quite rapidly between health-policy makers. Transferring some parts of the state hospitals ([@b21-ijph-41-14]) and more importantly changing some of state-owned hospitals to "Board of Trustees' hospitals" represent important steps toward the further privatization of health care delivery systems.

"Board of Trustees' hospitals" charge patients 3.6 times more than the official public sector medical tariffs ([@b21-ijph-41-14]). However, health insurance organizations reimburse patients based on the official tariffs in their reimbursement policy. This means that the patients have to pay the amount above the official tariffs out of their own pocket.

Discussion
==========

The interviewees emphasised the broad range of financial challenges currently facing the Iranian health care system. The issues raised by the interviewees and the empirical evidence cited suggest that the most important problem in financing health care delivery system is the lack of a systematic economic approach in the management and financing of the system. The ad hoc approach in determining medical tariffs provides a clear example of the potential benefits that would arise from a more detailed economic scrutiny. As remarked before, many of the interviewees stated that in their view the current medical tariffs had been set far below the market price of the services, which has imposed a wide array of financial problems for health care providers. The recent policy of the ministry of changing the state hospitals to "Board of Trustees' hospitals" would also appear to confirm this perception.

One of the main consequences of the low medical fees was a serious reduction in health care providers' income. This decrease inevitably led to a series of consequences at various levels of the healthcare system. At the general practitioner (GP) level, there is an obvious incentive to use their power to recommend, or induce demand for clinical services beyond those that are strictly necessary for the effective and efficient treatment of the patient. This supplier induced demand (SID) could be simply justified in economic terms with reference to "target income" theory ([@b22-ijph-41-14]) or simple "profit maximization" theory ([@b15-ijph-41-14]).

According to "income target" hypothesis, doctors have some "target income" in their mind that they seek to achieve. Thus, while the decision makers try to maintain the health expenditures in low level by controlling medical fees strictly, the doctors and other medical workers seek to find additional methods of increasing their income. Sharing profits of medical services would provide one such method of income generation to recompense for the below market value levels of medical fees.

The logical expectation from these arguments is increasing utilisation of medical services without any medical indication. This is clear example of technical inefficiency in health care services ([@b14-ijph-41-14],[@b15-ijph-41-14]). A wide range of recent studies also support this argument ([@b1-ijph-41-14],[@b9-ijph-41-14]). In addition to the problem of supplier-induced demand, private health care providers may face financial difficulties in covering the costs of their services. This has led them to compensate their financial shortage through unofficial or undertable fees.

This unofficial fee would increase the likelihood of two other negative consequences. Firstly, it may result in reduction of utilization of health care by patients who have difficulty affording such extra billing. As such patients are also those who are likely to be in greatest need of health care this will inevitably increase inequity in access to health care services ([@b23-ijph-41-14]). Secondly, the unofficial payment increases the share of individuals' payment for their health care expenditures. This will also enhance financial inequity in health care services ([@b16-ijph-41-14],[@b17-ijph-41-14],[@b24-ijph-41-14],[@b25-ijph-41-14]). This situation is occurring at the same time that a reduction in out of pocket spending of Iranians for health care services was clearly one of the main objectives of the Government's fourth development plan for the health care market ([@b26-ijph-41-14]). This plan stated that out-of-pocket spending of the population on healthcare should reduce from 60 percent to 30 percent by the end of the plan (March 2009) ([@b26-ijph-41-14]). But WHO data ([Table 1](#t1-ijph-41-14){ref-type="table"}) and local documents ([@b18-ijph-41-14]) and recent studies ([@b16-ijph-41-14],[@b17-ijph-41-14]) do not show such a trend in the health expenditure pattern of the Iranian population. The failure to achieve this objective led to the same target being repeated in the fifth development plan (2011--216) ([@b27-ijph-41-14]).

An increased government interest in the privatization of health care services, as one of the dominant health policies, has become apparent in recent years ([@b7-ijph-41-14]). However at the present the role of privatisation appears to be limited as it doesn't seem to adequately address efficiency, equity and how to protect patients against high cost services. Thus, enhancing the role of the private sector without addressing in detail its potential consequences may lead to further deterioration particularly in terms of equity of access. Moreover, the current objectives of five-year developing plan for health care system confirm that the ministry is still looking for ways to reduce out of pocket spending of the patients. This privatization policy does not seem to help the ministry to achieve its targets.

The results of this study emphasize that the healthcare market in Iran continues to face a wide range of complex financial issues. The ministry needs a clear, accurate and comprehensive policy to achieve the optimum trade-off between enhancing the health of the Iranian population and supporting health insurance organisations on the one hand, and providing cost effective high quality health care services on the other hand.

The establishment of a clear unifying national health policy would enable detailed consideration of the extent to which the established objectives are coherent and achievable. Such a policy should aim to achieve the goals of the health policy and should be based on evidence based medicine and Health Technology Assessment, rather than political pressures and tensions.

In conclusion, the health care market in Iran continues to face a range of financial issues, which increased the difficulty of achieving its defined healthcare objectives. In addressing these difficulties, further privatization of health care services can only play a limited role in managing such challenges at the time being. The first and most important step toward solving such challenges is to develop and implement a rational, feasible, and comprehensive policy that effectively addresses the current challenges and carefully considers the impact of the policy on the government, health insurance organizations, and patients. Such an approach supported by a rigorous economic analysis of the priorities and trade off inherent in the system would help health policy makers to confront the challenges of the system and to achieve their desired objectives more effectively.
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###### 

National Expenditures on Health

                                                                                              **1995**    **1996**     **1997**     **1998**     **1999**     **2000**     **2001**     **2002**     **2003[^\*\*\*^](#tfn4-ijph-41-14){ref-type="table-fn"}**   **2004**     **2005**      **2006**      **2007**      **2008**
  ------------------------------------------------------------------------------------------- ----------- ------------ ------------ ------------ ------------ ------------ ------------ ------------ ----------------------------------------------------------- ------------ ------------- ------------- ------------- -------------
  Total expenditure on health (Million US\$)[^\*^](#tfn2-ijph-41-14){ref-type="table-fn"}     8,652,828   13,219,043   15,988,423   19,299,998   25,872,594   34,228,946   41,130,149   56,885,993   68,164,827                                                  86,086,691   113,987,734   140,393,344   170,321,511   220,907,034
  Health Expenditure Growth Rate (%)                                                          \-\--       52.83        20.95        20.70        34.04        32.32        20.16        38.32        19.81                                                       26.31        32.41         23.16         21.32         29.70
  Private expenditure on health (Million US\$)[^\*^](#tfn2-ijph-41-14){ref-type="table-fn"}   4,334,993   7,109,605    8,664,450    10,577,211   16,051,639   21,560,040   23,972,261   32,343,928   36,462,859                                                  48,621,383   58,071,712    70,138,244    90,676,288    119,907,640
  Private Health Expenditure Growth Rate (%)                                                  \-\--       64.20        21.80        22.17        51.70        34.33        11.18        34.92        12.74                                                       33.35        19.44         20.79         29.28         32.23
  Out of pocket expenditure as % of PvtHE[^\*^](#tfn2-ijph-41-14){ref-type="table-fn"}        92.4        94.0         96.9         97.3         95.6         95.9         94.7         95.2         94.2                                                        95.3         95.4          95.4          95.4          95.2
  Inflation growth rate[^\*\*^](#tfn3-ijph-41-14){ref-type="table-fn"}                                                                                        11.4         15.8         15.6         15.2                                                        10.4         11.9          18.4          25.4          

Data Source:

WHO website /

Central Bank of Iran, various years /

by 2002 the monetary policy of the Iranian government was to devote subsidised currency to many products and services including health care services and pharmaceuticals. Thus while the expenditures of health care services increased significantly in 2003 in domestic market, it shows a decrease in its growth rate in terms of US dollar

###### 

The interviewees and their roles within the Iranian Health System

  **Designation**   **Position of the interviewees**
  ----------------- ---------------------------------------------------------------------------------------
  Dr 01             Academic, Senior Policy Maker of the Iranian Health System
  Dr 02             GP, Director of Regional Health Network
  Dr 03             Vice Chancellor of Medical University
  Dr 04             Senior staff, Medical Services Insurance Organisation
  Dr 05             Academic, Senior Policy Maker of the Iranian Health System
  Dr 06             Deputy of Medical Services Insurance Organisation
  Dr 07             Senior Manager in Social Security Health Insurance Organisation
  Dr 08             GP, Director of Regional Health Network
  Dr 09             Member of the Managing Board in Medical Services Insurance Organisation
  Dr 10             Chancellor, Medical University
  Dr 11             Specialist, Director of Hospital
  Dr 12             Health Scientist, Academic staff
  Dr 13             Health Scientist, Deputy Chancellor of Medical University
  Dr 14             GP, Director of Regional Health Network
  Dr 15             Pharmacist, Senior Staff, Food and Drug Department
  Dr 16             Deputy Chancellor of a Medical University in Food and Drug
  Dr 17             Pharmacologist, Academic Staff, Ex-Deputy Chancellor of a Medical University
  Dr 18             Deputy of Provincial Department of Imam Khomeini Health Insurance Organisation
  Dr 19             Executive manager of provincial department of Medical Services Insurance Organisation
  Dr 20             Director of Provincial Department Medical Services Insurance Organisation
  Dr 21             Member of management committee of Medical Services Insurance Organisation
